Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience

To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified se...

Descripción completa

Detalles Bibliográficos
Autores principales: Trama, Annalisa, Proto, Claudia, Whisenant, Jennifer G., Torri, Valter, Cortellini, Alessio, Michielin, Olivier, Barlesi, Fabrice, Dingemans, Anne-Marie C., Van Meerbeeck, Jan, Pancaldi, Vera, Mazieres, Julien, Soo, Ross A., Leighl, Natasha B., Peters, Solange, Wakelee, Heather, Horn, Leora, Hellmann, Matthew, Wong, Selina K., Garassino, Marina Chiara, Baena, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534826/
https://www.ncbi.nlm.nih.gov/pubmed/33091381
http://dx.doi.org/10.1016/j.ccell.2020.10.002
Descripción
Sumario:To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified several negative prognostic factors. In this commentary, we discuss the importance and limits of patient registries to support decision-making in thoracic cancer during the SARS-CoV-2 pandemic.

Ejemplares similares